Research and Markets: Sezary Syndrome - Pipeline Review, H1 2013 Contains Latest News and Deals Relating to the Products
Research and Markets (http://www.researchandmarkets.com/research/dwkhmk/sezary_syndrome) has announced the addition of the "Sezary Syndrome - Pipeline Review, H1 2013" report to their offering.
Global Markets Direct's, 'Sezary Syndrome - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Sezary Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sezary Syndrome. Sezary Syndrome - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
- A snapshot of the global therapeutic scenario for Sezary Syndrome.
- A review of the Sezary Syndrome products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Sezary Syndrome pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Shionogi & Co., Ltd.
- Innate Pharma SA
- Spectrum Pharmaceuticals, Inc.
For more information visit http://www.researchandmarkets.com/research/dwkhmk/sezary_syndrome
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.